People · Operator
Named in public records as an officer, director or promoter · active 2020–2024 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ArcherDX, Inc. | — | Other Health Care | Series C | $115.1M | $35.6M | 2020 |
| Manifold Biotechnologies, Inc. | — | Biotechnology | Series B | $78.2M | $198.4M | 2024 |
Steven J. Kafka at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven J. Kafka on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeff Huber | 1 | 75 |
| Kyle Lefkoff | 1 | 9 |
| Paul B. Manning | 1 | 6 |
| Paul Manning | 1 | 6 |
| Jason Myers | 1 | 4 |
| Jory Bell | 1 | 4 |
| Steven Holtzman | 1 | 3 |
| Todd Druley | 1 | 2 |
| Marvin H Caruthers | 1 | 2 |
| Marvin Caruthers | 1 | 2 |
| Kyle A. Lefkoff | 1 | 2 |
| Benjamin Carver | 1 | 1 |
| Britton A. Russell | 1 | 1 |
| Joshua C. Stahl | 1 | 1 |
| Christian LaPointe | 1 | 1 |
| Jason W. Myers | 1 | 1 |
| Jason C. Ryan | 1 | 1 |
| Steven Kafka | 1 | 1 |
| Joshua Stahl | 1 | 1 |
| Mark Massaro | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.